Riskpilot← Back to searchSign inGet full accessALIVA AS
ASActiveOrg 925021482Rigedalen 41, 4626 Kristiansand SManufacture of medical and dental instruments and supplies · NACE 3250Est. 20205 employees
Revenue 2025
NOK 0
EBITDA margin
—
-265% vs 2024
Equity ratio
89.1%
Financial strength
Net profit 2025
NOK -7,7M
-133% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -5,7M | -265% |
| Net profit | NOK -7,7M | -133% |
| Total assets | NOK 34,9M | +25% |
| Equity | NOK 31,2M | +31% |
| Employees | 5 | — |
Legal name
ALIVA AS
Org number
925021482
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
5. mai 2020
Share capital
NOK 84 986
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap. Daglig leder og ett styremedlem i fellesskap.
Company purpose
Produksjon av medisinske og tanntekniske instrumenter og utstyr, samt det som naturlig står i forbindelse med dette.
Address
Rigedalen 41, 4626 Kristiansand S
Email
birgitte@aliva.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 292 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −89 | −0 | −0 | −0 | −2 295 |
| EBITDA | −12 | −635 | −824 | −1 043 | −1 574 | −5 745 |
| Depreciation & amort. | −0 | −0 | −0 | −22 | −82 | −281 |
| EBIT | −12 | −635 | −824 | −1 065 | −1 657 | −6 026 |
| Net financials | 0 | −2 | −8 | −59 | −268 | −1 680 |
| Profit before tax | −12 | −638 | −832 | −1 124 | −1 925 | −7 706 |
| Tax | −0 | −0 | −893 | −494 | 1 388 | −0 |
| Net profit | −12 | −638 | 61 | −630 | −3 313 | −7 706 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 22 | 3 574 | 18 614 | 18 263 | 27 975 | 34 949 |
| Equity | 18 | −335 | 15 776 | 15 147 | 23 834 | 31 157 |
| Long-term debt | 0 | 2 400 | 2 400 | 2 400 | 2 100 | 1 400 |
| Short-term debt | 4 | 1 509 | 437 | 716 | 2 041 | 2 392 |
| Total debt | 4 | 3 909 | 2 837 | 3 116 | 4 141 | 3 792 |
EBITDA margin
-574496700.0%
This company
15.8%
Market median
-3636055163% vs market
20202025
Equity ratio
89.1%
This company
38.2%
Market median
+133% vs market
20202025
Return on equity
-24.7%
This company
18.4%
Market median
-234% vs market
20202025
Net profit margin
-770626000.0%
This company
8.1%
Market median
-9513901335% vs market
20202025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202025
Debt / equity
0.12×
This company
0.62×
Market median
+81% vs market
20202025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PF Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
BG Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2020 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Orstad Rådgivning As | Company | 17.8% | 17.8% | 2024 |
Hodne Invest As | Company | 17.8% | 17.8% | 2024 |
| Individual | 14.7% | 14.7% | 2022 | |
Alkymist As | Company | 12.3% | 12.3% | 2024 |
Csk Invest As | Company | 11.8% | 11.8% | 2024 |
Dolverhin Asalivator Holding As | Company | 11.3% | 11.3% | 2024 |
Jaz As | Company | 9.8% | 9.8% | 2024 |
Coins As | Company | 9.1% | 9.1% | 2024 |
Dolverhin Holding As | Company | 4.3% | 4.3% | 2024 |
Team Dental Norway As | Company | 3.2% | 3.2% | 2024 |
Anne-Lise Svandalsflona As | Company | 1.5% | 1.5% | 2024 |
Straumstad Invest As | Company | 1.1% | 1.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Matta As
ALIVA AS Board members of ALIVA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Preben Falkum | Chief Executive Officer | 0 companies |
| Birgitte Graverholt | Chief Executive Officer | 0 companies |
| Anders Stokkelien | Board of Directors | 0 companies |
| Cato Stene Kolstad | Board of Directors | 0 companies |
| Even Øgrey Brandsdal | Chairman | 0 companies |
| Sten Falkum | Board of Directors | 0 companies |
| Arne Damman | Chairman | 0 companies |
| Kjetil Gausel | Chairman | 0 companies |
| Rolf Smedvig Hodne | Board of Directors | 0 companies |
| Helge Orstad | Board of Directors | 0 companies |
| Anders Hommerstad | Board of Directors | 0 companies |